Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Iterum Therapeutics PLC - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
ITRM
Nasdaq
8731
https://www.iterumtx.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Iterum Therapeutics PLC
Iterum Therapeutics plc (NASDAQ:ITRM) Q4 2023 Earnings Call Transcript
- Apr 2nd, 2024 2:22 pm
Q4 2023 Iterum Therapeutics PLC Earnings Call
- Mar 29th, 2024 4:09 am
Iterum Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
- Mar 28th, 2024 11:00 am
Iterum Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024
- Mar 21st, 2024 8:30 pm
Iterum Therapeutics to Participate in H.C. Wainwright Virtual @Home Fireside Chat
- Mar 15th, 2024 12:00 pm
Iterum (ITRM) Plans Early Submission of UTI Drug NDA, Stock Up
- Mar 7th, 2024 12:57 pm
Iterum Therapeutics Provides Business Update
- Mar 6th, 2024 1:00 pm
Steven Cohen's Point72 Asset Management Acquires New Stake in Iterum Therapeutics PLC
- Feb 1st, 2024 8:03 pm
Iterum Therapeutics Announces Positive Topline Results from its Phase 3 REASSURE Clinical Trial of Oral Sulopenem in Uncomplicated Urinary Tract Infections
- Jan 30th, 2024 12:00 pm
Iterum Therapeutics Regains Compliance with Nasdaq Bid Price Rule
- Dec 4th, 2023 1:00 pm
Iterum Therapeutics plc (NASDAQ:ITRM) Q3 2023 Earnings Call Transcript
- Nov 15th, 2023 5:22 pm
Q3 2023 Iterum Therapeutics PLC Earnings Call
- Nov 15th, 2023 5:08 am
Iterum Therapeutics Reports Third Quarter 2023 Financial Results
- Nov 14th, 2023 12:00 pm
Iterum Therapeutics to Provide Business Update and Report Third Quarter 2023 Financial Results on November 14, 2023
- Nov 7th, 2023 1:30 pm
Iterum Therapeutics Announces Completion of Enrollment in its REASSURE Phase 3 Clinical Trial of Oral Sulopenem in Uncomplicated Urinary Tract Infections
- Oct 24th, 2023 12:00 pm
Iterum Therapeutics to Present Data at IDWeek 2023
- Oct 12th, 2023 1:15 pm
Q2 2023 Iterum Therapeutics PLC Earnings Call
- Aug 12th, 2023 2:10 am
Iterum Therapeutics Reports Second Quarter 2023 Financial Results
- Aug 11th, 2023 11:00 am
Iterum Therapeutics to Provide Business Update and Report Second Quarter 2023 Financial Results on August 11, 2023
- Aug 4th, 2023 9:00 pm
Avalo (AVTX) Fails to Meet Goal in Asthma Study, Stock Down 89%
- Jun 27th, 2023 1:50 pm
Scroll